An expert review report released by the Food and Drug Administration (FDA) Monday raised doubts as to whether the vaccine developed by Taiwan-based United Biomedical Inc. (UBI) Asia offers sufficient protection against COVID-19 variants.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 0.27%
06/25/2024 02:04 PM - Society
CWA heat advisory continues across Taiwan
06/25/2024 01:20 PM - Politics
U.S. condemns China's latest move toward Taiwan as 'destabilizing'
06/25/2024 11:52 AM - Business
U.S. dollar up in Taipei trading
06/25/2024 11:12 AM - Society
Taiwan headline news
06/25/2024 10:26 AM